ERLOTINIB FOR JAPANESE PATIENTS WITH RELAPSED SQUAMOUS CELL CARCINOMA OF THE LUNG

被引：0
|
作者：
Hata, Akito
Kei, Kunimasa
Hiroshige, Yoshioka
Shiro, Fujita
Reiko, Kaji
Ryo, Tachikawa
Keisuke, Tomii
Tadashi, Ishida
Nobuyuki, Katakami
机构：
来源：
RESPIROLOGY | 2010年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [1] Erlotinib for Pretreated Squamous Cell Carcinoma of the Lung in Japanese Patients
    Hata, Akito
    Katakami, Nobuyuki
    Kunimasa, Kei
    Yoshioka, Hiroshige
    Fujita, Shiro
    Kaji, Reiko
    Tachikawa, Ryo
    Tomii, Keisuke
    Imai, Yukihiro
    Iwasaku, Masahiro
    Ishida, Tadashi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (12) : 1366 - 1372
  • [2] EVALUATING THE EFFICACY OF ERLOTINIB FOR PATIENTS WITH RELAPSED SQUAMOUS CELL CARCINOMA OF THE LUNG
    Hata, Akito
    Yoshioka, Hiroshige
    Katakami, Nobuyuki
    Fujita, Shiro
    Tabata, Yoshie
    Kaji, Reiko
    Tachikawa, Ryou
    Takeshima, Yoshimi
    Hayashi, Michio
    Tomii, Keisuke
    Iwasaku, Masahiro
    Kunimasa, Kei
    Nishiyama, Akihiro
    Ishida, Tadashi
    ANNALS OF ONCOLOGY, 2010, 21 : 26 - 26
  • [3] Erlotinib in patients with advanced lung squamous cell carcinoma
    Chiang, Chi-Lu
    Tsai, Chun-Ming
    Chou, Teh-Ying
    Chen, Yuh-Min
    Lai, Shinn-Liang
    Shih, Jen-Fu
    Chiu, Chao-Hua
    Lee, Yu-Chin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 203 - 208
  • [4] Erlotinib in patients with advanced lung squamous cell carcinoma
    Chi-Lu Chiang
    Chun-Ming Tsai
    Teh-Ying Chou
    Yuh-Min Chen
    Shinn-Liang Lai
    Jen-Fu Shih
    Chao-Hua Chiu
    Yu-Chin Lee
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 203 - 208
  • [5] Erlotinib in patients with advanced squamous cell carcinoma of the lung.
    Gúrpide, A.
    Massuti, B.
    Pallares, C.
    Salinas, P.
    Montes, A.
    López-Vivanco, G.
    Barón, M. González
    Cobo, M.
    Amador, M. L.
    Paz-Ares, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 407S - 407S
  • [6] Erlotinib for Squamous Cell Carcinoma of the Lung A Prospective Phase II Study
    Kim, Eun Kyoung
    Choi, Chang-Min
    Lee, Dae Ho
    Choi, Jene
    Jang, Se Jin
    Suh, Cheolwon
    Lee, Jung Shin
    Kim, Sang-We
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S399 - S399
  • [7] Safety and efficacy of erlotinib in patients with squamous cell lung cancer
    Jakopovic, Marko
    Cucevic, Branka
    Plestina, Sanja
    Smojver-Jezek, Silvana
    Kukulj, Suzana
    Chalfe, Nabil
    Korsic, Marta
    Vrbica, Zarko
    Redzepi, Gzim
    Samarzija, Miroslav
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [8] Efficacy of gefitinib or erlotinib in patients with squamous cell lung cancer
    Song, Zhengbo
    Zhang, Yiping
    ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (01) : 164 - 168
  • [9] EGFR TKI Erlotinib in Patients with Advanced Squamous Cell Carcinoma of the Lung: A Retrospective Analysis from India
    Arya, Devavrat
    Singhal, Manish K.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S761 - S761
  • [10] Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung
    Lu, Shun
    Li, Wei
    Zhou, Caicun
    Hu, Cheng-Ping
    Qin, Shukui
    Cheng, Gang
    Feng, Jifeng
    Wang, Jie
    Cseh, Agnieszka
    Peil, Barbara
    Gibson, Neil
    Ehrnrooth, Eva
    Zhang, Li
    ONCOTARGETS AND THERAPY, 2018, 11 : 8565 - 8573
12345